News | February 26, 2009

Magnetic Particle Imaging Generates Real-Time Blood Flow, Heart Movement Images

February 26, 2009 - The first 3D imaging results obtained with a new imaging technology called Magnetic Particle Imaging (MPI) produced reportedly unprecedented real-time images of arterial blood flow and volumetric heart motion, reported Royal Philips Electronics.

The technology uses the magnetic properties of iron-oxide nanoparticles injected into the bloodstream and has been used in a pre-clinical studies. This is said to represent a major step forward in taking Magnetic Particle Imaging from a theoretical concept to an imaging tool to help improve diagnosis and therapy planning for many of the world’s major diseases, such as heart disease, stroke and cancer. The results of the pre-clinical study were published in issue 54 of Physics in Medicine and Biology (2009).

“A novel noninvasive cardiac imaging technology is required to further unravel and characterize the disease processes associated with atherosclerosis, in particular those associated with vulnerable plaque formation which is a major risk factor for stroke and heart attacks,” said Professor Valentin Fuster, M.D., Ph.D., director of the Mount Sinai Heart Center, New York. “Through its combined speed, resolution and sensitivity, Magnetic Particle Imaging technology has great potential for this application, and the latest in-vivo imaging results represent a major breakthrough.”

According to Henk van Houten, senior vice president of Philips Research and head of the Healthcare research program, “By adding important functional information to the anatomical data obtained from existing modalities such as CT and MR, Philips’ MPI technology has the potential to significantly help in the diagnosis and treatment planning of major diseases such as atherosclerosis and congenital heart defects.”

Philips’ Magnetic Particle Imaging uses the magnetic properties of injected iron-oxide nanoparticles to measure the nanoparticle concentration in the blood. Because the human body contains no naturally occurring magnetic materials visible to MPI, there is no background signal. After injection, the nanoparticles therefore appear as bright signals in the images, from which nanoparticle concentrations can be calculated. By combining high spatial resolution with short image acquisition times (as short as 1/50th of a second), Magnetic Particle Imaging can capture dynamic concentration changes as the nanoparticles are swept along by the blood stream. This could ultimately allow MPI scanners to perform a wide range of functional cardiovascular measurements in a single scan. These could include measurements of coronary blood supply, myocardial perfusion, and the heart’s ejection fraction, wall motion and flow speeds.

The results obtained from Philips’ experimental MPI scanner mark an important step towards the development of a whole-body system for use on humans. Some of the technical challenges in scaling up the system relate to the magnetic field generation required for human applications. Others lie in the measurement and processing of the extremely weak signal emitted by the nanoparticles. Signal measurement and processing are areas where Philips has a great deal of proven expertise and experience that it is currently applying to the task.

The scientific article “Three-dimensional real-time in vivo magnetic particle imaging” published in issue 54 of Physics in Medicine and Biology (2009) can be downloaded from http://stacks.iop.org/0031-9155/54/L1.

For more information: www.medical.philips.com

Related Content

Videos | Cardiac Imaging| December 29, 2017
ITN and DAIC Editor Dave Fornell takes a tour of some of the most interesting new medical imaging technologies on the
Siemens Healthineers Introduces Share360 Tailored Service Portfolio
News | Cardiac Imaging| November 10, 2017
To address the specific needs of medical imaging clinical engineering departments nationwide, Siemens Healthineers has...
HeartFlow's FFR-CT (FFRct) analysis software can create a virtual FFR to assess coronary artery disease.

HeartFlow's FFR-CT analysis software uses a computed tomography scan and supercomputing fluid dynamics software to create a noninvasive, virtual FFR map of the entire coronary artery tree to determine the flow-limiting severity of ant lesions. 

News | Cardiac Imaging| November 06, 2017
November 6, 2017 – The Centers for Medicare & Medicaid Services (CMS) has finalized a New Technology Ambulatory P
Philips Announces Findings of Patient Experience in Imaging Research
News | Cardiac Imaging| October 24, 2017
Philips recently announced the key findings of its research focused on the patient experience in diagnostic imaging...
ASNC and SNMMI Release Joint Document on Diagnosis, Treatment of Cardiac Sarcoidosis
News | Cardiac Imaging| August 18, 2017
August 18, 2017 — The American Society of...
Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Cardiac Imaging| August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
Videos | Cardiac Imaging| July 18, 2017
Leslee Shaw, Ph.D., director of clinical research and professor of medicine at Emory University, Atlanta, and past-pr

Physicians will need to use a CMS-certified appropriate use criteria (AUC) clinical decision support software that documents the appropriateness of an imaging order to receive full reimbursement for Medicare patients starting Jan. 1, 2018.

Feature | Cardiac Imaging| April 18, 2017 | Dave Fornell
As part of U.S. healthcare reform efforts, starting Jan.
Philips, cardiology solutions, ACC.17, Azurion angiography system, iFR outcomes results, IntelliSpace Cardiovascular
News | Cardiac Imaging| March 24, 2017
At the 2017 American College of Cardiology's Annual Scientific Session & Expo (ACC.17), Philips showcased a broad...
Siemens Healthineers, ACC 2017, syngot CTO Guidance, Compressed Sensing Cardiac Cine
News | Cardiac Imaging| March 16, 2017
During the 66th Annual Scientific Session & Expo of the American College of Cardiology (ACC), March 17-19 in...
Overlay Init